Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Gomes, Isabele B S ^a   Porto, Marcella L ^a   Santos, Maria Carmen L F S ^b   Campagnaro, Bianca P ^b   Pereira, Thiago M C ^b   Meyrelles, Silvana S ^a   Vasquez, Elisardo C ^a,b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b UNIVERSIDADE VILA VELHA   (Brazil)

Author keywords

Apoptosis; Diabetic nephropathy; Flavonoids; Oxidative stress; Quercetin

Indexed keywords

CHOLESTEROL; CREATININE; QUERCETIN; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; UREA; URIC ACID; ANTIOXIDANT; GLUCOSE BLOOD LEVEL; LIPID;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIAPOPTOTIC EFFECT; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CELL VIABILITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DRUG ACTIVITY; DRUG MECHANISM; DRUG RESPONSE; DRUG SCREENING; FLOW CYTOMETRY; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERTRIGLYCERIDEMIA; KIDNEY CELL; KIDNEY FUNCTION; LOW DRUG DOSE; MORPHOMETRICS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; POLYURIA; PROTEINURIA; RENAL PROTECTION; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; WEIGHT GAIN; ANIMAL; BLOOD; C57BL MOUSE; COMPLICATION; DIABETIC NEPHROPATHIES; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; KIDNEY; LIPIDS; MICE, INBRED C57BL; OXIDATIVE STRESS; QUERCETIN;

EID: 84975784273     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-184     Document Type: Article

References (78)

1. Anjaneyulu M, Chopra K: Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2004, 31(4):244-248.
2. Lin CY, Yin MC: Renal protective effects of extracts from guava fruit (Psidium guajava L.) in diabetic mice. Plant Foods Hum Nutr 2012, 67(3):303-308.
3. Aires Neto P, Gomes HV, Campos M: Management of hyperglycemia in patients with chronic kidney disease. J Nephrol 2013, 26(4):629-635.
4. Vallon V, Rose M, Gerasimova M, Satriano J, Platt KA, Koepsell H, Cunard R, Sharma K, Thomson SC, Rieg T: Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am J Physiol Renal Physiol 2013, 304(2):F156-F167.
5. Powell DW, Kenagy DN, Zheng S, Coventry SC, Xu J, Cai L, Carlson EC, Epstein PN: Associations between structural and functional changes to the kidney in diabetic humans and mice. Life Sci 2013, 93(7):257-264.
6. Brown WV: Microvascular complications of diabetes mellitus: renal protection accompanies cardiovascular protection. Am J Cardiol 2008, 102(12A):10L-13L.
7. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414(6865):813-820.
8. Tan AL, Forbes JM, Cooper ME: AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 2007, 27(2):130-143.
9. Campbell KN, Raij L, Mundel P: Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr Diabetes Rev 2011, 7(1):3-7.
10. Singh R, Kishore L, Kaur N: Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol Res 2014, 80:21-35.
11. Ozcelik D, Tuncdemir M, Ozturk M, Uzun H: Evaluation of trace elements and oxidative stress levels in the liver and kidney of streptozotocin-induced experimental diabetic rat model. Gen Physiol Biophys 2011, 30(4):356-363.
12. Stanton RC: Oxidative stress and diabetic kidney disease. Curr Diab Rep 2011, 11(4):330-336.
13. Tachibana H, Ogawa D, Sogawa N, Asanuma M, Miyazaki I, Terami N, Hatanaka T, Horiguchi CS, Nakatsuka A, Eguchi J, Wada J, Yamada H, Takei K, Makino H: Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice. Am J Physiol Renal Physiol 2014, 306(1):F105-F115.
14. Marrazzo G, Barbagallo I, Galvano F, Malaguarnera M, Gazzolo D, Frigiola A, D'Orazio N, Li Volti G: Role of dietary and endogenous antioxidants in diabetes. Crit Rev Food Sci Nutr 2014, 54(12):1599-1616.
15. Like AA, Rossini AA: Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976, 193(4251):415-417.
16. Tesch GH, Allen TJ: Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 2007, 12(3):261-266.
17. Vasquez EC, Johnson RF, Beltz TG, Haskell RE, Davidson BL, Johnson AK: Replication-deficient adenovirus vector transfer of gfp reporter gene into supraoptic nucleus and subfornical organ neurons. Exp Neurol 1998, 154(2):353-365.
18. Vasquez EC, Peotta VA, Gava AL, Pereira TM, Meyrelles SS: Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse. J Biomed Sci 2012, 19:22.
19. Nogueira BV, Peotta VA, Meyrelles SS, Vasquez EC: Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice. Arch Med Res 2007, 38(8):816-821.
20. Pereira TM, Nogueira BV, Lima LC, Porto ML, Arruda JA, Vasquez EC, Meyrelles SS: Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids Health Dis 2010, 19(9):87.
21. Breyer MD, Böttinger E, Brosius FC 3rd, Coffman TM, Harris RC, Heilig CW, Sharma K, AMDCC: Mouse models of diabetic nephropathy. J Am Soc Nephrol 2005, 16(1):27-45.
22. Brosius FC 3rd, Alpers CE: New targets for treatment of diabetic nephropathy: what we have learned from animal models. Curr Opin Nephrol Hypertens 2013, 22(1):17-25.
23. Tavafi M: Diabetic nephropathy and antioxidants. J Nephropathol 2013, 2(1):20-27.
24. Cooper ME: Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001, 44(11):1957-1972.
25. Cai X, Fang Z, Dou J, Yu A, Zhai G: Bioavailability of quercetin: problems and promises. Curr Med Chem 2013, 20(20):2572-2582.
26. Pérez-Gregorio MR, Regueiro J, Simal-Gándara J, Rodrigues AS, Almeida DP: Increasing the added-value of onions as a source of antioxidant flavonoids: a critical review. Crit Rev Food Sci Nutr 2014, 54(8):1050-1062.
27. Olson ER, Melton T, Dong Z, Bowden GT: Stabilization of quercetin paradoxically reduces its proapoptotic effect on UVB-irradiated human keratinocytes. Cancer Prev Res (Phila) 2008, 1(5):362-368.
28. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, Osuna A: Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 2009, 61(1):67-75.
29. Bischoff SC: Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 2008, 11(6):733-740.
30. Coqueiro A, Regasini LO, Skrzek SC, Queiroz MM, Silva DH, da Silva Bolzani V: Free radical scavenging activity of Kielmeyera variabilis Clusiaceae). Molecules 2013, 18(2):2376-2385.
31. Machha A, Mustafa MR: Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J Cardiovasc Pharmacol 2005, 46(1):36-40.
32. Ajay M, Achike FI, Mustafa AM, Mustafa MR: Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2006, 73(1):1-7.
33. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
34. Campagnaro BP, Tonini CL, Nogueira BV, Casarini DE, Vasquez EC, Meyrelles SS: DNA damage and augmented oxidative stress in bone marrow mononuclear cells from Angiotensin-dependent hypertensive mice. Int J Hypertens 2013, 2013:305202.
35. Rodrigues BP, Campagnaro BP, Balarini CM, Pereira TM, Meyrelles SS, Vasquez EC: Sildenafil ameliorates biomarkers of genotoxicity in an experimental model of spontaneous atherosclerosis. Lipids Health Dis 2013, 28(12):128.
36. Dias AT, Rodrigues BP, Porto ML, Gava AL, Balarini CM, Freitas FP, Palomino Z, Casarini DE, Campagnaro BP, Pereira TM, Meyrelles SS, Vasquez EC: Sildenafil ameliorates oxidative stress and DNA damage in the stenotic kidneys in mice with renovascular hypertension. J TranslMed 2014, 6(12):35.
37. Monga J, Pandit S, Chauhan RS, Chauhan CS, Chauhan SS, Sharma M: Growth inhibition and apoptosis induction by (+)-Cyanidan-3-ol in hepatocellular carcinoma. PLoS One 2013, 8(7):e68710.
38. Wang C, Pan Y, Zhang QY, Wang FM, Kong LD: Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One 2012, 7(6):e38285.
39. Mogensen CE, Christensen CK, Vittinghus E: The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983, 32(Suppl 2):64-78.
40. Jerums G, Panagiotopoulos S, Premaratne E, MacIsaac RJ: Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol 2009, 5(7):397-406.
41. Kraynak AR, Storer RD, Jensen RD, Kloss MW, Soper KA, Clair JH, DeLuca JG, Nichols WW, Eydelloth R: Extent and persistence of streptozotocin-induced DNA damage and cell proliferation in rat kidney as determined by in vivo alkaline elution and BrdUrd labeling assays. Toxicol Appl Pharmacol 1995, 135(2):279-286.
42. Ortega A, Fernández A, Arenas MI, López-Luna P, Muñóz-Moreno C, Arribas I, Olea N, García-Bermejo L, Lucio-Cazana J, Bosch RJ: Outcome of acute renal injury in diabetic mice with experimental endotoxemia: role of hypoxia-inducible factor-1 α. J Diabetes Res 2013, 2013:254529.
43. Oršolić N, Gajski G, Garaj-Vrhovac V, Dikić D, Prskalo ZŠ, Sirovina D: DNA-protective effects of quercetin or naringenin in alloxan-induced diabetic mice. Eur J Pharmacol 2011, 656(1-3):110-118.
44. Ortega R, García N: The flavonoid quercetin induces changes in mitochondrial permeability by inhibiting adenine nucleotide translocase. J Bioenerg Biomembr 2009, 41(1):41-47.
45. Sesink AL, O'Leary KA, Hollman PC: Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4′-glucoside. J Nutr 2001, 131(7):1938-1941.
46. Pereira Braga C, Momentti AC, Barbosa Peixoto F, de Fátima Ferreira Baptista R, dos Santos FA, Fava FH, Fernandes AA: Influence of treatment with quercetin on lipid parameters and oxidative stress of pregnant diabetic rats. Can J Physiol Pharmacol 2013, 91(2):171-177.
47. Molina MF, Sanchez-Reus I, Iglesias I, Benedi J: Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol Pharm Bull 2003, 26(10):1398-1402.
48. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M: Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001, 108(9):1341-1348.
49. Moreira PI, Rolo AP, Sena C, Seiça R, Oliveira CR, Santos MS: Insulin attenuates diabetes-related mitochondrial alterations: a comparative study. Med Chem 2006, 2(3):299-308.
50. Blake R, Trounce IA: Mitochondrial dysfunction and complications associated with diabetes. Biochim Biophys Acta 2014, 1840(4):1404-1412.
51. Vessal M, Hemmati M, Vasei M: Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 2003, 135C(3):357-364.
52. Kobori M, Masumoto S, Akimoto Y, Takahashi Y: Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol Nutr Food Res 2009, 53(7):859-868.
53. Kim JH, Kang MJ, Choi HN, Jeong SM, Lee YM, Kim JI: Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr Res Pract 2011, 5(2):107-111.
54. Kanter M, Aktas C, Erboga M: Protective effects of quercetin against apoptosis and oxidative stress in streptozotocin-induced diabetic rat testis. Food Chem Toxicol 2012, 50(3-4):719-725.
55. Xu M, Hu J, Zhao W, Gao X, Jiang C, Liu K, Liu B, Huang F: Quercetin differently regulates insulin-mediated glucose transporter 4 translocation under basal and inflammatory conditions in adipocytes. Mol Nutr Food Res 2014, 58(5):931-941.
56. Alam MM, Meerza D, Naseem I: Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci 2014, 109(1):8-14.
57. Sarkhail P, Rahmanipour S, Fadyevatan S, Mohammadirad A, Dehghan G, Amin G, Shafiee A, Abdollahi M: Antidiabetic effect of Phlomis anisodonta: effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Pharmacol Res 2007, 56(3):261-266.
58. Ishikawa A, Yamashita H, Hiemori M, Inagaki E, Kimoto M, Okamoto M, Tsuji H, Memon AN, Mohammadio A, Natori Y: Characterization of inhibitors of postprandial hyperglycemia from the leaves of Nerium indicum. J Nutr Sci Vitaminol (Tokyo) 2007, 53(2):166-173.
59. Kwon O, Eck P, Chen S, Corpe CP, Lee JH, Kruhlak M, Levine M: Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J 2007, 21(2):366-377.
60. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002, 287(19):2570-2581.
61. Jeong SM, Kang MJ, Choi HN, Kim JH, Kim JI: Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr Res Pract 2012, 6(3):201-207.
62. Negi B, Kaur R, Dey G: Protective effects of a novel sea buckthorn wine on oxidative stress and hypercholesterolemia. Food Funct 2013, 4(2):240-248.
63. Elbe H, Vardi N, Esrefoglu M, Ates B, Yologlu S, Taskapan C: Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Hum Exp Toxicol 2014, 1-14. Epub ahead of print.
64. Chen P, Chen J, Zheng Q, Chen W, Wang Y, Xu X: Pioglitazone, extract of compound Danshen dripping pill, and quercetin ameliorate diabetic nephropathy in diabetic rats. J Endocrinol Invest 2013, 36(6):422-427.
65. Lai PB, Zhang L, Yang LY: Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-ß1 and connective tissue growth factor in streptozotocin-induced diabetic rats. Ren Fail 2012, 34(1):83-87.
66. Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA: Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products. J Am Soc Nephrol 2004, 15(8):2125-2138.
67. Xu S, Jiang B, Maitland KA, Bayat H, Gu J, Nadler JL, Corda S, Lavielle G, Verbeuren TJ, Zuccollo A, Cohen RA: The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice. Diabetes 2006, 55(1):110-119.
68. Chan EC, Pannangpetch P, Woodman OL: Relaxation to flavones and flavonols in rat isolated thoracic aorta: mechanism of action and structure-activity relationships. J Cardiovasc Pharmacol 2000, 35(2):326-333.
69. Lodi F, Jimenez R, Moreno L, Kroon PA, Needs PW, Hughes DA, Santos-Buelga C, Gonzalez-Paramas A, Cogolludo A, Lopez-Sepulveda R, Duarte J, Perez-Vizcaino F: Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis 2009, 204(1):34-39.
70. Schena FP, Gesualdo L: Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 2005, 16(Suppl 1):S30-S33.
71. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM: Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 1989, 320(15):966-970.
72. Liu CM, Sun YZ, Sun JM, Ma JQ, Cheng C: Protective role of quercetin against lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKs and NF-?B pathway. Biochim Biophys Acta 2012, 1820(10):1693-1703.
73. Dong YS, Wang JL, Feng DY, Qin HZ, Wen H, Yin ZM, Gao GD, Li C: Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage. Int J Med Sci 2014, 11(3):282-290.
74. Tonini CL, Campagnaro BP, Louro LP, Pereira TM, Vasquez EC, Meyrelles SS: Effects of aging and hypercholesterolemia on oxidative stress and DNA damage in bone marrow mononuclear cells in apolipoprotein E-deficient mice. Int J Mol Sci 2013, 14(2):3325-3342.
75. Liu CM, Ma JQ, Sun YZ: Quercetin protects the rat kidney against oxidative stress-mediated DNA damage and apoptosis induced by lead. Environ Toxicol Pharmacol 2010, 30(3):264-271.
76. Ishikawa Y, Kitamura M: Anti-apoptotic effect of quercetin: intervention in the JNK-and ERK-mediated apoptotic pathways. Kidney Int 2000, 58(3):1078-1087.
77. Liu CM, Zheng YL, Lu J, Zhang ZF, Fan SH, Wu DM, Ma JQ: Quercetin protects rat liver against lead-induced oxidative stress and apoptosis. Environ Toxicol Pharmacol 2010, 29(2):158-166.
78. Boots AW, Haenen GR, Bast A: Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008, 585(2-3):325-337.